179 related articles for article (PubMed ID: 1954887)
1. Monoclonal antibodies specific for rat relaxin. V. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts development of the mammary apparatus and, hence, lactational performance in rats.
Hwang JJ; Lee AB; Fields PA; Haab LM; Mojonnier LE; Sherwood OD
Endocrinology; 1991 Dec; 129(6):3034-42. PubMed ID: 1954887
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies specific for rat relaxin. VII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy prevents development of normal mammary nipple morphology and function in rats.
Kuenzi MJ; Sherwood OD
Endocrinology; 1992 Oct; 131(4):1841-7. PubMed ID: 1396329
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies specific for rat relaxin. IV. Passive immunization with monoclonal antibodies during the antepartum period reduces cervical growth and extensibility, disrupts birth, and reduces pup survival in intact rats.
Hwang JJ; Shanks RD; Sherwood OD
Endocrinology; 1989 Jul; 125(1):260-6. PubMed ID: 2737147
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies specific for rat relaxin. II. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts birth in intact rats.
Guico-Lamm ML; Sherwood OD
Endocrinology; 1988 Nov; 123(5):2479-85. PubMed ID: 3168930
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies specific for rat relaxin. VIII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces water consumption in rats.
Zhao S; Malmgren CH; Shanks RD; Sherwood OD
Endocrinology; 1995 May; 136(5):1892-7. PubMed ID: 7720635
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific for rat relaxin. VI. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts histological changes associated with cervical softening at parturition in rats.
Lee AB; Hwang JJ; Haab LM; Fields PA; Sherwood OD
Endocrinology; 1992 Apr; 130(4):2386-91. PubMed ID: 1547746
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies specific for rat relaxin. III. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces cervical growth and extensibility in intact rats.
Hwang JJ; Sherwood OD
Endocrinology; 1988 Nov; 123(5):2486-90. PubMed ID: 3168931
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies specific for rat relaxin. IX. Evidence that endogenous relaxin promotes growth of the vagina during the second half of pregnancy in rats.
Zhao S; Kuenzi MJ; Sherwood OD
Endocrinology; 1996 Feb; 137(2):425-30. PubMed ID: 8593785
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies specific for rat relaxin. X. Endogenous relaxin induces changes in the histological characteristics of the rat vagina during the second half of pregnancy.
Zhao S; Sherwood OD
Endocrinology; 1998 Nov; 139(11):4726-34. PubMed ID: 9794485
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies specific for rat relaxin. I. Production and characterization of monoclonal antibodies that neutralize rat relaxin's bioactivity in vivo.
Guico-Lamm ML; Voss EW; Sherwood OD
Endocrinology; 1988 Nov; 123(5):2472-8. PubMed ID: 3168929
[TBL] [Abstract][Full Text] [Related]
11. Immuno-neutralization of circulating relaxin does not alter the breast cancer-protective action of parity in MNU-treated rats.
Steinetz BG; Sherwood OD; Lasano S; Horton L; Bosland MC
J Exp Ther Oncol; 2004 Apr; 4(1):59-68. PubMed ID: 15255292
[TBL] [Abstract][Full Text] [Related]
12. Relaxin acts directly on rat mammary nipples to stimulate their growth.
Kuenzi MJ; Connolly BA; Sherwood OD
Endocrinology; 1995 Jul; 136(7):2943-7. PubMed ID: 7789319
[TBL] [Abstract][Full Text] [Related]
13. The physiological effects of relaxin during pregnancy: studies in rats and pigs.
Sherwood OD; Downing SJ; Guico-Lamm ML; Hwang JJ; O'Day-Bowman MB; Fields PA
Oxf Rev Reprod Biol; 1993; 15():143-89. PubMed ID: 8336976
[TBL] [Abstract][Full Text] [Related]
14. The source and secretion of immunoactive relaxin in rat milk.
Steinetz BG; Horton L; Lasano S
Exp Biol Med (Maywood); 2009 May; 234(5):562-5. PubMed ID: 19234058
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of specific relaxin-binding cells in the cervix, mammary glands, and nipples of pregnant rats.
Kuenzi MJ; Sherwood OD
Endocrinology; 1995 Apr; 136(4):1367-73. PubMed ID: 7895647
[TBL] [Abstract][Full Text] [Related]
16. The extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats.
Lee HY; Zhao S; Fields PA; Sherwood OD
Endocrinology; 2005 Jan; 146(1):511-8. PubMed ID: 15498891
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
18. Effects of relaxin on lactational performance in ovariectomized gilts.
Zaleski HM; Winn RJ; Jennings RL; Sherwood OD
Biol Reprod; 1996 Sep; 55(3):671-5. PubMed ID: 8862786
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of relaxin within the brain affects the timing of birth in rats.
Summerlee AJ; Ramsey DG; Poterski RS
Endocrinology; 1998 Feb; 139(2):479-84. PubMed ID: 9449614
[TBL] [Abstract][Full Text] [Related]
20. Normal mammary gland growth and lactation capacity in pregnant relaxin-deficient mice.
Parry LJ; Vodstrcil LA; Madden A; Amir SH; Baldwin K; Wlodek ME; Nicholas KR
Reprod Fertil Dev; 2009; 21(4):549-60. PubMed ID: 19383261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
